PharmaBizConnect begins a new chapter in the Indian Pharma industry

PharmaBizConnect is one of the pioneers of the PCD Pharma business model in India and has been able to help many individuals and agencies in this process.

Press Release ( - Panchkula, Haryana - Mar 31, 2019 - The sector of PCD Pharma has been progressing swiftly in the recent two decades. The growth of the pharma sector has been estimated in two digits in recent years although these estimates are derived by keeping only the top 100 pharma marketing companies in consideration. On the contrary, if the surveyor could recognize the contributions of PCD Pharma Companies, then the growth figures would be substantially higher.

Even though the PCD pharma sector has been labeled as an unorganized sector, the contributions of the sector to the improvement of awareness in the healthcare sector as well as the well being of people could not be undermined. The CEO and MD of PharmaBizConnect stated that the PCD pharma franchise business ensures positive and profitable outcomes for all stakeholders and everyone involved gets to take something back home. He also added that “Our vision to accomplish a win-win situation for everyone involved on our platform is rightly supported and boosted by our services for pharma franchise companies to exhibit their products and services on our online platform. Service seekers from all over the country could view these exhibitions and reach out to the companies directly”.

The operations of the PharmaBizConnect platform enable pharma franchisers to use digital media for advertising their company and the new range of pharmaceutical products developed by them. Pharma franchisers are generally associated with a third party contract manufacturer for the production of pharmaceuticals with the brand name of the franchiser. Franchise companies could connect with these franchisers on PharmaBizConnect directly and negotiate deals if their requirements align with each other.

This new mode of launching, establishing and expanding pharma businesses is appealing to a multitude of entrepreneurs. The problem of supply is resolved considerably along with the option to select the franchiser according to requirements after comprehensive interaction. PharmaBizConnect has been able to garner the trust of many service providers and service seeking professionals and agencies over the years.

The success of the platform has been attributed to the competencies and abilities of the founders of PharmaBizConnect, Rajneesh Gupta. His experience in the pharma industry, as well as other industry verticals such as training, sales, consulting and marketing, helped the company translate an innovative idea into a full-fledged solution for the pharma sector.

The online platform has helped many pharma professionals to ensure time savings by providing easy search options. Visitors could be able to search for companies according to the zones registered on the searching platform.

About The Company

PharmaBizConnect is a reliable third party solution for connecting pharma franchisers with franchisees. Startup professionals could make the most of the services of PharmaBizConnect to catch up on the trend of PCD pharma business model. The services of PharmaBizConnect are aptly tailored for the growth and development of PCD Pharma Companies in India. Furthermore, the unique abilities and foresight of the founders, Mr. Rajneesh Gupta has been responsible for the company’s success in helping many PCD Pharma Franchises in the country.

Contact Information


Rajneesh Gupta

Phone: +917388111103



Source : Follow on Google News


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.